Lipella Pharmaceuticals Profit Margin

Lipella Pharmaceuticals (LIPO) currently reports a profit margin of -1185.15% as of September 2025. That compares with -1098.53% in the prior-year period — down 7.9% year over year. That is below the sector sector average of 19.61%. Use the charts on this page to explore Lipella Pharmaceuticals's profit margin history and peer comparisons.

Lipella Pharmaceuticals's profit margin decreased from -1098.53% to -1185.15% — a 7.9% year-over-year decrease (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Lipella Pharmaceuticals's profit margin of -1185.15% is lower than the its sector sector average of 19.61%. That is roughly 6144.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Lipella Pharmaceuticals's current -1185.15% should be judged against industry norms (sector average: 19.61%) and against LIPO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -1185.15%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 19.61%. From there, open related valuation or income-statement pages for Lipella Pharmaceuticals, and consider following LIPO for alerts when major investors trade the stock.